Assessing Markov and Time Homogeneity Assumptions in Multi-state Models: Application in Patients with Gastric Cancer Undergoing Surgery in the Iran Cancer Institute |
Zare, Ali
(Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences)
Mahmoodi, Mahmood (Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences) Mohammad, Kazem (Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences) Zeraati, Hojjat (Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences) Hosseini, Mostafa (Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences) Naieni, Kourosh Holakouie (Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences) |
1 | Foulkes A, De Gruttola V (2003). Characterizing the progression of viral mutations over time. J Am Stat Assoc, 98, 859-67. DOI ScienceOn |
2 | Gentleman R, Lawless J, Lindsey J, Yan P (1994). Multi-state Markov models for analysing incomplete disease history data with illustrations for hiv disease. Stat Med, 13, 805-21. DOI ScienceOn |
3 | Grambsch PM, Therneau TM (1994). Proportional hazards tests and diagnostics based on weighted residuals. Biometrika, 81, 515-526. DOI ScienceOn |
4 | Healy B, Degruttola V (2007). Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses. Biostatistics, 8, 438-52. DOI ScienceOn |
5 | Hosmer Jr DW, Lemeshow S, May S (2011). Applied survival analysis: regression modeling of time to event data: Wiley-Interscience. |
6 | Hsieh HJ, Chen THH, Chang SH (2002). Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan. Stat Med, 21, 3369-82. DOI ScienceOn |
7 | Jackson CH (2011). Multi-state models for panel data: the msm package for R. J Stat Software, 38, 1-29. |
8 | Kalbfleisch J, Lawless JF (1985). The analysis of panel data under a Markov assumption. J Am Stat Assoc, 80, 863-71. DOI ScienceOn |
9 | Chen P-L, Tien H-C (2004). Semi-Markov models for multistate data analysis with periodic observations. Communications in Statistics: Theory and Methods, 33, 475-86. DOI ScienceOn |
10 | Collett D (2003) Modelling survival data in medical research: CRC press. |
11 | De Stavola BL (1988). Testing departures from time homogeneity in multistate Markov processes. App Stat, 33, 242-50. |
12 | Akaike H (1980). Likelihood and the Bayes procedure. Trabajos de Estadistica y de Investigacion Operativa, 31, 143-66. DOI |
13 | Akaike H (1998). A new look at the statistical model identification. In Selected Papers of Hirotugu Akaike, pp. 215-222. |
14 | Faddy M (1976). A note on the general time-dependent stochastic compartmental model. Biometrics, 443-8. |
15 | Foucher Y, Giral M, Soulillou J, Daures J (2010). A flexible semi-Markov model for interval-censored data and goodness-of-fit testing. Stat Methods Med Res, 19, 127-45. DOI ScienceOn |
16 | Peto R, Peto J (1972). Asymptotically efficient rank invariant test procedures. J Royal Stat Soc, 185-207. |
17 | Perez-Ocon R, Ruiz-Castro JE, Gamiz-Perez ML (2000). Markov models with lognormal transition rates in the analysis of survival times. Test, 9, 353-70. DOI |
18 | Ruiz-Castro JE & Perez-Ocon R (2004) A semi-Markov model in biomedical studies. |
19 | Perez-Ocon R, Ruiz-Castro JE, Gamiz-Perez ML (2001). Nonhomogeneous Markov models in the analysis of survival after breast cancer. J Royal Stat Society, 50, 111-24. DOI ScienceOn |
20 | Razavi SE, Aaghajani H, Haghazali M, et al (2009) The most common cancers in Iranian women. Iranian J Public Health, 38, 109-12. |
21 | Sadighi S, Mohagheghi M, Haddad P, et al (2008). Life expectancy with perioperative chemotherapy and chemoradiotherapy for locally advanced gastric adenocarcinoma. TUMJ, 66, 664-9. |
22 | Sadighi S, Raafat J, Mohagheghi M, Meemary F (2005). Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev, 6, 195-6. |
23 | American Joint Committee on Cancer (2002). AJCC Cancel Staging Manual. 6th ed. New York. NY: Springer. pp 99-106. |
24 | Anderson DR (2008). Model based inference in the life sciences: a primer on evidence. |
25 | Association JGC (2011). Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer, 14, 113-23. DOI ScienceOn |
26 | Chen P-L, Bernard EJ, Sen PK (1999). A Markov chain model used in analyzing disease history applied to a stroke study. J App Stat, 26, 413-22. DOI ScienceOn |
27 | Kay R (1986). A Markov model for analysing cancer markers and disease states in survival studies. Biometrics, 855-865. |
28 | Weissfeld LA, Schneider H (1990). Influence diganostics for the Weibull model fit to censored data. Stat & Probability Lett, 9, 67-73. DOI ScienceOn |
29 | Kang M & Lagakos SW (2007). Statistical methods for panel data from a semi-Markov process, with application to HPV. Biostatistics 8, 252-264. DOI ScienceOn |
30 | Kalbfleisch JD, Prentice RL (2011). The statistical analysis of failure time data: John Wiley & Sons. |
31 | Klein JP, Moeschberger ML (2003). Survival analysis: techniques for censored and truncated data: Springer. |
32 | Klein JP, Zhang MJ (2005). Survival analysis, software: Wiley Online Library. |
33 | Mathieu E, Loup P, Dellamonica P, Daures J (2005). Markov Modelling of Immunological and Virological States in HIV-1 Infected Patients. Biometrical J, 47, 834-46. DOI ScienceOn |
34 | Meira-Machado L, de Una-Alvarez J, Cadarso-Suarez C, Andersen PK (2009). Multi-state models for the analysis of time-to-event data. Stat Methods Med Res, 18, 195-222. |
35 | Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in tehran metropolis: the first report from the tehran population-based cancer registry. Archives Iranian Med, 12, 15-23. |
36 | Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63. |
37 | Ocan-Riola R (2005). Non-homogeneous Markov processes for biomedical data analysis. Biometrical J, l47, 369-76. |
38 | Omar RZ, Stallard N, Whitehead J (1995). A parametric multistate model for the analysis of carcinogenicity experiments. Lifetime Data Analysis, 1, 327-46. DOI |
39 | Saint-Pierre P, Combescure C, Daures J, Godard P (2003). The analysis of asthma control under a Markov assumption with use of covariates. Stat Med, 22, 3755-70. DOI ScienceOn |
40 | Samadi F, Babaei M, Yazdanbod A, et al (2007). Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med, 10, 32-7. |
41 | Sharples L, Taylor G, Faddy M (2001). A piecewisehomogeneous Markov chain process of lung transplantation. J Epidemiol and Biostatistics, 6, 349-55. DOI |
42 | Titman A (2008). Model diagnostics in multi-state models of biological systems, PhD Thesis, University of Cambridge, UK. |
43 | Titman AC (2011). Flexible nonhomogeneous Markov models for panel observed data. Biometrics, 67, 780-7. DOI ScienceOn |
44 | Titman AC (2012). Estimating parametric semi-Markov models from panel data using phase-type approximations. Statistics and Computing, 1-10. |
45 | Titman AC, Sharples LD (2010a). Model diagnostics for multistate models. Stat Methods Med Res, 19, 621-51. DOI ScienceOn |
46 | Titman AC, Sharples LD (2010b). Semi-Markov Models with phase-type sojourn distributions. Biometrics, 66, 742-52. DOI ScienceOn |
47 | Mohagheghi MA (2004). Annual report of Tehran cancer registery 1999: Cancer institute publication. |
48 | Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA: Cancer J Clin, 55, 74-108. DOI ScienceOn |
49 | Escobar LA, Meeker Jr WQ (1992). Assessing influence in regression analysis with censored data. Biometrics, 48, 507-28. DOI ScienceOn |
![]() |